Total

CGRP Medication

Erenumab

Fremanezumab

Galcanezumab

Eptinezumab

Age Mean (SD)

40.2

(13.1)

40.6

(13.5)

40.8

(13.0)

38.7

(12.4)

23.0

.

Biologic Sex

  Male

13

(17.1)

5

(38.5)

6

(46.2)

2

(15.4)

.

.

  Female

63

(82.9)

25

(39.7)

30

(47.6)

7

(11.1)

1

(1.6)

Aura

  No

56

(73.7)

26

(46.4)

22

(39.3)

7

(12.5)

1

(1.8)

  Yes

20

(26.3)

4

(20.0)

14

(70.0)

2

(10.0)

.

.

Photo/Phono Phobia

  No

7

(9.2)

3

(42.9)

4

(57.1)

.

.

.

.

  Yes

69

(90.8)

27

(39.1)

32

(46.4)

9

(13.0)

1

(1.4)

Nausea & Vomiting

  No

14

(18.4)

2

(14.3)

9

(64.3)

3

(21.4)

.

.

  Yes

62

(81.6)

28

(45.2)

27

(43.5)

6

(9.7)

1

(1.6)

Autonomic Symptoms

  No

65

(85.5)

25

(38.5)

31

(47.7)

8

(12.3)

1

(1.5)

  Yes

11

(14.5)

5

(45.5)

5

(45.5)

1

(9.1)

.

.

Chronic Migraine

  No

21

(27.6)

6

(28.6)

12

(57.1)

3

(14.3)

.

.

  Yes

55

(72.4)

24

(43.6)

24

(43.6)

6

(10.9)

1

(1.8)

Post-Traumatic

  No

70

(92.1)

25

(35.7)

35

(50.0)

9

(12.9)

1

(1.4)

  Yes

6

(7.9)

5

(83.3)

1

(16.7)

.

.

.

.

BMI > 30

   No

42

(55.3)

   Yes

34

(44.7)

Total

76

(100.0)

30

(39.5)

36

(47.4)

9

(11.8)

1

(1.3)